EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta‐analysis

Anne-Sofie H Jensen iD, Marie Winther-Sørensen iD, Johan Burisch iD, Annika Bergquist iD, Henriette Ytting iD, Lise L Gluud iD, Nicolai J Wewer Albrechtsen iD

Liver International · 2023

DOI: 10.1111/liv.15720 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Liver International, 2023. Verfasst von Anne-Sofie H Jensen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Liver Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Patients with some chronic liver diseases have increased risk of diabetes. Whether this is also the case for patients with autoimmune liver diseases is unknown. The study aimed to calculate risk and worldwide prevalence of diabetes in patients with autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).

Methods

We performed a case–control study using data from the United Kingdom Biobank (UKB) and compared frequency of type 1 diabetes (T1D) and type 2 diabetes (T2D) in AIH and PBC with age‐, sex‐, BMI‐ and ethnicity‐matched controls. Next, we performed a systematic review and proportional meta‐analysis searching PubMed, Embase, Cochrane Library and Web of Science (inception to 1 May 2022 [AIH]; 20 August 2022 [PBC]; 11 November 2022 [PSC]). The pooled prevalence of diabetes was calculated using an inverse method random effects model.

Results

Three hundred twenty‐eight AIH patients and 345 PBC patients were identified in UKB and risk of T1D and T2D significantly increased compared with matched controls. Our systematic search identified 6914 records including the UKB study. Of these, 77 studies were eligible for inclusion comprising 36 467, 39 924 and 4877 individuals with AIH, PBC and PSC, respectively. The pooled prevalence of T1D was 3.8% (2.6%–5.7%), 1.7% (0.9%–3.1%), 3.1% (1.9%–4.8%) and of T2D 14.8% (11.1%–19.5%), 18.1% (14.6%–22.2%), 6.3% (2.8%–13.3%) in patients with AIH, PBC and PSC, respectively.

Conclusions

Patients with autoimmune liver diseases have increased risk of diabetes. Increased awareness of diabetes risk in patients with autoimmune liver diseases is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Cirrhosis, BiliaryDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Liver DiseasesAutoimmune DiseasesHepatitis, AutoimmuneCholangitis, SclerosingHumansCase-Control StudiesPropensity Score

Stichwörter der Autor:innen

UK Biobankautoimmune hepatitisglucoseoverlap syndromeprimary biliary cholangitisprimary sclerosing cholangitis

Autor:innen und Institutionen

  • Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre Hospital, Hvidovre, Denmark.
  • Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark.

ORCID-Profile: Anne-Sofie H Jensen, Marie Winther-Sørensen, Johan Burisch, Annika Bergquist, Henriette Ytting, Lise L Gluud, Nicolai J Wewer Albrechtsen

Zitieren

APA

Jensen, A. H., Winther-Sørensen, M., Burisch, J., Bergquist, A., Ytting, H., Gluud, L. L., & Wewer Albrechtsen, N. J. (2023). Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta‐analysis. Liver International. https://doi.org/10.1111/liv.15720

Vancouver

Jensen AH, Winther-Sørensen M, Burisch J, Bergquist A, Ytting H, Gluud LL, et al. Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta‐analysis. Liver International. 2023. doi:10.1111/liv.15720

BibTeX
@article{Jensen2023,
  author = {Jensen, Anne-Sofie H and Winther-Sørensen, Marie and Burisch, Johan and Bergquist, Annika and Ytting, Henriette and Gluud, Lise L and Wewer Albrechtsen, Nicolai J},
  title = {Autoimmune liver diseases and diabetes: A propensity score matched analysis and a proportional meta‐analysis},
  journal = {Liver International},
  year = {2023},
  doi = {10.1111/liv.15720}
}
Kostenlos starten →